Home Page Overall Ranking ROE Ranking P/E Ranking Dividend Yield Capitalization Our eBook Our Book Contact










Isin CA91911K1021
Ticker VRX
Company VALEANT PHARMACEUTICALS INTERNATIONAL
Currency $
Price
Aware Investor Index (AII) 0.0000
Recommendation STRONG SELL
P/E 239.46
ROE 1.20 %
Capitalization 15,616,795,000 $
Dividend Yield 0.00 %
P/S 1.89
AII Position 776
P/E Position 766
ROE Position 779
Capitalization Position 415
Dividend Yield Position 629
Sales 8,263,500,000 $
10-Year Average Earnings 65,217,000 $
Shares Outstanding 341,500,000
Equity 5,434,500,000 $
Dividend per Share 0 $
Industry Pharmaceutical
Country Canada
VALEANT PHARMACEUTICALS INTERNATIONAL Investor Relations Web Site http://ir.valeant.com







Sales:

YEAR MONTH AMOUNT
2014 12 8,263,500,000.00 $
2013 12 5,769,605,000.00 $

Earnings:

YEAR MONTH AMOUNT
2014 12 913,500,000.00 $
2013 12 -866,142,000.00 $
2012 12 -116,025,000.00 $
2011 12 159,559,000.00 $
2010 12 -208,193,000.00 $
2009 12 176,455,000.00 $
2008 12 199,904,000.00 $
2007 12 103,541,000.00 $
2006 12 228,939,000.00 $
2005 12 60,632,000.00 $

Equity:

YEAR MONTH AMOUNT
2014 12 5,434,500,000.00 $
2013 12 5,233,322,000.00 $
2012 12 3,717,398,000.00 $

Shares Outstanding:

YEAR MONTH AMOUNT
2014 12 341,500,000
2013 12 320,996,000
2012 12 303,861,000

 












Bloomberg News for VALEANT PHARMACEUTICALS INTERNATIONAL:

Jan 3, 2011
U.S. Stock Options With Biggest Changes in Implied Volatility
1368 SSO PROSHARES U SSO US 01/22/11 C40 16.9 53.7 9.27 14.4 517 VRX VALEANT PHA VRX US 01/22/11 C26 16.8 47.4 3.05 -7.6 1000 CSCO CISCO SYSTE CSCO US 01/22/11...
Jan 6, 2011
U.S. Stock Options With Biggest Changes in Implied Volatility
1500 CVE CENOVUS ENE CVE US 03/19/11 C22.5 17.3 55.9 10.30 -5.5 500 VRX VALEANT PHA VRX US 01/22/11 C32 17.1 38.9 3.30 407.7 1291 CSX CSX CORP CSX US 01/22/11...
Aug 4, 2011
Iridian Asset Mgmt Holdings in 2nd Quarter: 13F Alert
(USD $) Position In Position Valeant Pharmaceuticals Inte VRX US 295,603,506 5,689,059 -1,052,171 Wyndham Worldwide Corp WYN US 274,946...
Sep 28, 2011
Allon, PetroAmerica, Rare Element, TMX: Canadian Equity Preview
offered to buy TMX for C$3.73 billion ($3.65 billion). Valeant Pharmaceuticals International Inc. (VRX CN): The drugmaker received approval for colesevelam hydrochloride, a treatment to help lower LDL...
Nov 10, 2011
Zweig Dimenna Partners Holdings in 3rd Quarter: 13F Alert
Freeport-McMoRan Copper FCX US -21,681,938 173,360 -336,295 Valeant Pharmaceuticals Inte VRX US -20,560,233 124,345 -360,180 Williams Cos Inc WMB US -17,574...
Apr 21, 2011
ARC Resources, Celestica, Silver Wheaton: Canada Equity Preview
Steven Butler, an analyst at Canaccord Financial Inc. Valeant Pharmaceuticals International Inc. (VRX CN): Canada’s largest drugmaker said it is prepared to “modestly” raise its bid for Cephalon Inc...
Oct 2, 2008
North and South American Stock Rating Changes, New Coverage
-------------------------------------------------------------------------------- Valeant Pharmaceuticals Inte (VRX US) Matrix/Lighthouse Analyst Recommendation Action Target Team Coverage...
Feb 15, 2011
ValueAct Holdings Largest Holdings in 4th Qtr: 13F Alert
(USD $) Position In Position Valeant Pharmaceuticals Inte VRX US 762,695,599 26,959,901 Sara Lee Corp SLE US 611,428...
Feb 14, 2011
Brahman Capital Corp Largest Holdings in 4th Quarter: 13F Alert
Technologies Holding ST US 70,728,842 2,349,015 2,349,015 Valeant Pharmaceuticals Inte VRX US 65,248,056 2,306,400 -254,700 Xerox Corp XRX US 57,273...
Dec 1, 2003
A New Way To Fight Hepatitis C
better at bypassing the blood cells and going straight to the liver. Valeant Pharmaceuticals (VRX), formerly ICN Pharma-ceuticals (ICN), developed both drugs. And it announced in early November...


Google News for VALEANT PHARMACEUTICALS INTERNATIONAL:

Barron's - 21 hours ago
Valeant: Out of the Frying Pan, Into the Fire
Shares of Valeant Pharmaceuticals International (VRX) spiked yesterday on speculation regarding a possible debt-to-equity swap by the ...
Sports Perspectives
Valeant Pharmaceuticals International Reaches Analyst Target Price
In recent trading, shares of Valeant Pharmaceuticals International Inc (Symbol: VRX) have crossed above the average analyst 12-month target ...
Evergreen Caller
Valeant Pharma: A Debt Swap?
Why are shares of Valeant Pharmaceuticals International (VRX) ... Today, a 7.8% spike in Valeant's share price is linked to speculation that a ...
Investing News Update
Are Options Traders Betting on a Big Move in Valeant ...
Investors in Valeant Pharmaceuticals International, Inc.VRX need to pay close attention to the stock based on moves in the options market ...
Nasdaq - 1 day ago
Levels in View For Valeant Pharmaceuticals International Inc (VRX ...
The present 14-day ATR for Valeant Pharmaceuticals International Inc (VRX.TO) is currently sitting at 1.09. The ATR basically measures the ...
Equities.com
Valeant Pharmaceuticals International Inc (VRX.TO) Sees VMA ...
Shares of Valeant Pharmaceuticals International Inc (VRX.TO) have seen the volume moving average (VMA) climb over the past seven ...
Reuters
Short Term: Valeant Pharmaceuticals International, Inc. (VRX ...
At the time of writing, Valeant Pharmaceuticals International, Inc. (VRX) is standing at value of $16.65 with the falling stream of -2.52%.
TopChronicle
Valeant: Is This Time Different?
Valeant (NYSE:VRX) is edging higher, leaving investors to once again wonder if this time is different. Is the low really in? Unfortunately no-one ...
Barron's - 1 day ago
Valeant: Let's Talk Pipeline And Value
Valeant (NYSE:VRX) stock has seen some heavy swings in the last few ... When looking at other specialty pharmaceutical companies a large ...
Nasdaq - 1 day ago
Valeant Pharmaceuticals International, Inc. (VRX): Ignore the noise ...
With all other things going on, Valeant Pharmaceuticals International, Inc. (NYSE:VRX) has been on a run — rising 55.9 percent in just three ...


Back